DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,690.00
+290.00 (8.53%)
Apr 1, 2026, 3:30 PM KST
DK Life Science Company Description
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally.
It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments.
The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software.
DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.
DK Life Science Co., Ltd.
| Country | South Korea |
| Founded | 2017 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 100 |
| CEO | Jae Won Park |
Contact Details
Address: Teheran-ro 108-gil 7 Seoul South Korea | |
| Phone | 82 2 3452 7639 |
| Website | dkls.co.kr |
Stock Details
| Ticker Symbol | 303810 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7303810006 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jae Won Park | Chief Executive Officer |
| Ki-Cheol Kim | Chief Financial Officer |